Advertisement
Home Authors Posts by Ariel Jones-DeMaio

Ariel Jones-DeMaio

21 POSTS 0 COMMENTS
video

The Future of BCMA-Targeting in Myeloma

video

bb21217 Shows Encouraging Efficacy, Safety, and CAR T-Cell Expansion

Combination of Venetoclax, Obinutuzumab, and Atezolizumab Shows Promise in Richter’s Transformation

MRD-Guided Ibrutinib Combination Successful in Relapsed/Refractory Chronic Lymphocytic Leukemia

Evaluating Adoptive Immunotherapy to Prevent Acute GVHD

Evaluating Fixed-Duration Ibrutinib and Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia

Ibrutinib Plus Ianalumab Shows Promising Results in Early-Phase Trial

Peripheral Blood Cytopenias Could Represent an Early Marker of Cancer Mortality...

Older Patients With Newly Diagnosed CLL Benefit From Frontline Targeted Treatment

GLOW: MRD Outcomes After Fixed-Duration Ibrutinib Combinations in Older CLL Patients

123Page 1 of 3
Advertisement
Advertisement
© Copyright 2018 Academy of Managed Care Pharmacy | 675 North Washington Street, Suite 220, Alexandria, VA 22314 | 703-684-2600 · Privacy Policy · meetings@amcp.org